166 related articles for article (PubMed ID: 38091580)
21. HIV-genetic diversity and drug resistance transmission clusters in Gondar, Northern Ethiopia, 2003-2013.
Arimide DA; Abebe A; Kebede Y; Adugna F; Tilahun T; Kassa D; Assefa Y; Balcha TT; Björkman P; Medstrand P
PLoS One; 2018; 13(10):e0205446. PubMed ID: 30304061
[TBL] [Abstract][Full Text] [Related]
22. Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi.
Bello G; Kagoli M; Chipeta S; Auld A; Chang JC; DeVos JR; Kim E; Mkungudza J; Payne D; Eliya M; Nyirenda R; Jahn A; Mzumara T; Mvula B; Dadabhai S; Namakhoma I; Babaye Y; Giron A; Jordan MR; Bertagnolio S; O'Malley G; Wadonda-Kabondo N
Antivir Ther; 2022 Aug; 27(4):13596535221121225. PubMed ID: 35976773
[TBL] [Abstract][Full Text] [Related]
23. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
[TBL] [Abstract][Full Text] [Related]
24. High Levels of Acquired HIV Drug Resistance Following Virological Nonsuppression in HIV-Infected Women from a High-Risk Cohort in Uganda.
Segujja F; Omooja J; Lunkuse S; Nanyonjo M; Nabirye SE; Nassolo F; Bugembe DL; Bbosa N; Kateete DP; Ssenyonga W; Mayanja Y; Nsubuga RN; Seeley J; Kaleebu P; Ssemwanga D
AIDS Res Hum Retroviruses; 2020 Sep; 36(9):782-791. PubMed ID: 32475121
[TBL] [Abstract][Full Text] [Related]
25. Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings.
Zhang G; DeVos J; Medina-Moreno S; Wagar N; Diallo K; Beard RS; Zheng DP; Mwachari C; Riwa C; Jullu B; Wangari NE; Kibona MS; Ng'Ang'A LW; Raizes E; Yang C
PLoS One; 2018; 13(9):e0203296. PubMed ID: 30192818
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of pretreatment HIV drug resistance in key populations: a systematic review and meta-analysis.
Macdonald V; Mbuagbaw L; Jordan MR; Mathers B; Jay S; Baggaley R; Verster A; Bertagnolio S
J Int AIDS Soc; 2020 Dec; 23(12):e25656. PubMed ID: 33369131
[TBL] [Abstract][Full Text] [Related]
27. HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy.
Avila-Ríos S; García-Morales C; Tapia-Trejo D; Meza RI; Nuñez SM; Parham L; Flores NA; Valladares D; Pineda LM; Flores D; Motiño R; Umanzor V; Carbajal C; Murillo W; Lorenzana I; Palou EY; Reyes-Terán G
PLoS One; 2015; 10(11):e0142604. PubMed ID: 26558396
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 drug resistance-associated mutations among HIV-1 infected drug-naïve antenatal clinic attendees in rural Kenya.
Kiptoo M; Brooks J; Lihana RW; Sandstrom P; Ng'ang'a Z; Kinyua J; Lagat N; Okoth F; Songok EM
BMC Infect Dis; 2013 Nov; 13():517. PubMed ID: 24180455
[TBL] [Abstract][Full Text] [Related]
29. Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999-2018.
Ismael N; Wilkinson E; Mahumane I; Gemusse H; Giandhari J; Bauhofer A; Vubil A; Mambo P; Singh L; Mabunda N; Bila D; Engelbrecht S; Gudo E; Lessells R; de Oliveira T
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146798
[TBL] [Abstract][Full Text] [Related]
30. Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: A Retrospective longitudinal study from rural coastal Kenya.
Hassan AS; Bibby DF; Mwaringa SM; Agutu CA; Ndirangu KK; Sanders EJ; Cane PA; Mbisa JL; Berkley JA
PLoS One; 2019; 14(2):e0210559. PubMed ID: 30759103
[TBL] [Abstract][Full Text] [Related]
31. Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings.
Manyana S; Pillay M; Gounder L; Khan A; Moodley P; Naidoo K; Chimukangara B
AIDS Res Ther; 2023 Feb; 20(1):9. PubMed ID: 36759801
[TBL] [Abstract][Full Text] [Related]
32. Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study.
Kan W; Teng T; Liang S; Ma Y; Tang H; Zuohela T; Sun G; He C; Wall KM; Marconi VC; Liao L; Leng X; Liu P; Ruan Y; Xing H; Shao Y
BMJ Open; 2017 Sep; 7(9):e016012. PubMed ID: 28882911
[TBL] [Abstract][Full Text] [Related]
33. Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected Kenyan children with treatment failure.
Lwembe R; Ochieng W; Panikulam A; Mongoina CO; Palakudy T; Koizumi Y; Kageyama S; Yamamoto N; Shioda T; Musoke R; Owens M; Songok EM; Okoth FA; Ichimura H
J Med Virol; 2007 Jul; 79(7):865-72. PubMed ID: 17516531
[TBL] [Abstract][Full Text] [Related]
34. Trends in HIV-1 pretreatment drug resistance and HIV-1 variant dynamics among antiretroviral therapy-naive Ethiopians from 2003 to 2018: a pooled sequence analysis.
Kiros M; Biset S; Gebremariam B; Yalew GT; Abegaz WE; Geteneh A
Virol J; 2023 Oct; 20(1):243. PubMed ID: 37880705
[TBL] [Abstract][Full Text] [Related]
35. High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016.
Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Román M; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Juárez SI; Ravasi G; Vargas C; Gutiérrez R; Romero L; Solórzano A; Sajquim E; Northbrook S; Ávila-Ríos S; Reyes-Terán G
J Int AIDS Soc; 2019 Dec; 22(12):e25429. PubMed ID: 31860167
[TBL] [Abstract][Full Text] [Related]
36. HIV type 1 subtype diversity and drug resistance among HIV type 1-infected Kenyan patients initiating antiretroviral therapy.
Lihana RW; Khamadi SA; Lubano K; Lwembe R; Kiptoo MK; Lagat N; Kinyua JG; Okoth FA; Songok EM; Makokha EP; Ichimura H
AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1211-7. PubMed ID: 19954302
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment and Acquired Antiretroviral Drug Resistance Among Persons Living With HIV in Four African Countries.
Crowell TA; Danboise B; Parikh A; Esber A; Dear N; Coakley P; Kasembeli A; Maswai J; Khamadi S; Bahemana E; Iroezindu M; Kiweewa F; Owuoth J; Freeman J; Jagodzinski LL; Malia JA; Eller LA; Tovanabutra S; Peel SA; Ake JA; Polyak CS;
Clin Infect Dis; 2021 Oct; 73(7):e2311-e2322. PubMed ID: 32785695
[TBL] [Abstract][Full Text] [Related]
38. Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.
Nanfack AJ; Redd AD; Bimela JS; Ncham G; Achem E; Banin AN; Kirkpatrick AR; Porcella SF; Agyingi LA; Meli J; Colizzi V; Nádas A; Gorny MK; Nyambi PN; Quinn TC; Duerr R
J Clin Microbiol; 2017 Sep; 55(9):2785-2800. PubMed ID: 28659324
[TBL] [Abstract][Full Text] [Related]
39. Genetic diversity and antiretroviral resistance-associated mutation profile of treated and naive HIV-1 infected patients from the Northwest and Southwest regions of Cameroon.
Meriki HD; Tufon KA; Anong DN; Atanga PN; Anyangwe IA; Cho-Ngwa F; Nkuo-Akenji T
PLoS One; 2019; 14(11):e0225575. PubMed ID: 31751428
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of HIV-1 drug resistance among patients failing first-line antiretroviral therapy in Ethiopia.
Getaneh Y; He Q; Rashid A; Kassa D; Kang L; Yi F; Liao L; Shao Y
J Glob Antimicrob Resist; 2022 Sep; 30():418-427. PubMed ID: 35917929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
